Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accredited, Agriculture, alanine, ALT, aminotransferase, aspartate, AST, attained, auditor, blinded, bond, capsule, CIII, clarity, comment, confined, debarment, defective, dissolution, Goldman, guide, hedge, hepatic, involuntary, necessity, NGM, numerically, pari, passu, PCAOB, Pfizer, prespecified, proton, provisional, quantity, radiolabeled, ranking, referencing, registry, relationship, Sanofi, Secretary, Squibb, tablet, thousand, tightening, unaudited, underwritten, undesirable, untitled, vital, Welfare
Filing tables
Filing exhibits
Related press release
MDGL similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-187242, No. 333-206135, No. 333-219304) and Form S-8 (No. 333-141903, No. 333-152824, No. 333-173862, No. 333-181117, No. 333-187243, No. 333-194477, No. 333-202680, No. 333-206128, No. 333-212615) of Madrigal Pharmaceuticals, Inc. of our report dated March 13, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 13, 2018
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM